Koning

Executive Summary

Koning is a US-based medical device company specializing in advanced breast imaging technology. Its flagship product, the Koning Vera Breast CT (KBCT), utilizes cone-beam computed tomography to generate high-resolution, true 3D images of the breast without the need for compression. This innovation aims to improve early cancer detection, streamline diagnostic workups, and enhance image-guided biopsy procedures. Founded in 2002 and headquartered in West Henrietta, New York, Koning operates in the competitive medical diagnostics and devices space, targeting a significant need for more accurate and comfortable breast imaging alternatives to traditional mammography. Despite being a private company with limited publicly available financial data, Koning's technology holds promise in reducing false positives and improving patient experience. The company's long development timeline suggests a focus on regulatory milestones and clinical validation, positioning it for potential growth as adoption of dedicated breast CT expands.

Upcoming Catalysts (preview)

• Q4 2026FDA Clearance for Expanded Indications or Software Upgrade70% success
• Q2 2027Publication of Clinical Study Results Demonstrating Superiority Over Mammography60% success
• Q3 2026Partnership or Distribution Agreement with a Major Hospital Network50% success